Xeloda News
Most Popular Xeloda Story
ALSO NOTED: Europe expands Synvisc approval; FDA issues "approvable" letter for paliperidone; and much more...
> European regulators have agreed to expand the approval of Genzyme's Synvisc to include osteoarthritis of the ankle and shoulder. Report
> J&J says its subsidiary has received an approvable letter from the FDA for paliperidone as a therapy for schizophrenia. But the drug maker did not say what issues were still left to be resolved. …
Read more...Latest Headlines
- April 2, 2006
- February 12, 2006
- November 1, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
